Evaluation of morbidity in Schistosoma mansoni-positive primary and secondary school children after four years of mass drug administration of praziquantel in western Kenya
Abstract Background World Health Organization guidelines recommend preventive chemotherapy with praziquantel to control morbidity due to schistosomiasis. The primary aim of this cross-sectional study was to determine if 4 years of annual mass drug administration (MDA) in primary and secondary school...
Main Authors: | Bernard O. Abudho, Bernard Guyah, Bartholomew N. Ondigo, Eric M. Ndombi, Edmund Ireri, Jennifer M. Carter, Diana K. Riner, Nupur Kittur, Diana M. S. Karanja, Daniel G. Colley |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-06-01
|
Series: | Infectious Diseases of Poverty |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40249-020-00690-7 |
Similar Items
-
Evidence Against Rapid Emergence of Praziquantel Resistance in Schistosoma haematobium, Kenya
by: Charles H. King, et al.
Published: (2000-12-01) -
Interactions between schistosomiasis and human immunodeficiency virus in Western Kenya
by: W Evan Secor, et al.
Published: (2004-08-01) -
A high-intensity cluster of Schistosoma mansoni infection around Mbita causeway, western Kenya: a confirmatory cross-sectional survey
by: Evans Asena Chadeka, et al.
Published: (2019-04-01) -
Young Adults in Endemic Areas: An Untreated Group in Need of School-Based Preventive Chemotherapy for Schistosomiasis Control and Elimination
by: Harrison K. Korir, et al.
Published: (2018-09-01) -
Praziquantel is an effective drug for the treatment of Schistosoma Mansoni infection among school-aged children in Northwest Ethiopia
by: Addisu Tesfie, et al.
Published: (2020-04-01)